This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Feb 7;8(3):120.

doi: 10.1038/nrneurol.2012.15.

Neuromuscular disease. A novel imaging method to quantify low levels of dystrophin in Duchenne muscular dystrophy

PMID: 22310989
DOI: 10.1038/nrneurol.2012.15

Comment

Neuromuscular disease. A novel imaging method to quantify low levels of dystrophin in Duchenne muscular dystrophy

Katy Malpass. Nat Rev Neurol. 2012.

. 2012 Feb 7;8(3):120.

doi: 10.1038/nrneurol.2012.15.

Author

PMID: 22310989
DOI: 10.1038/nrneurol.2012.15

No abstract available

PubMed Disclaimer

Comment in

Correspondence: Measuring dystrophin-faster is not necessarily better.
Arechavala-Gomeza V, Feng L, Morgan JE, Muntoni F. Arechavala-Gomeza V, et al. Nat Rev Neurol. 2012 Aug;8(8):469. doi: 10.1038/nrneurol.2012.15-c1. Epub 2012 Jul 10. Nat Rev Neurol. 2012. PMID: 22777248 No abstract available.

Comment on

Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
Sadan O, Shemesh N, Barzilay R, Dadon-Nahum M, Blumenfeld-Katzir T, Assaf Y, Yeshurun M, Djaldetti R, Cohen Y, Melamed E, Offen D. Sadan O, et al. Exp Neurol. 2012 Apr;234(2):417-27. doi: 10.1016/j.expneurol.2011.12.045. Epub 2012 Jan 20. Exp Neurol. 2012. PMID: 22285250

References

1. Neuropathol Appl Neurobiol. 2012 Oct;38(6):591-601 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.